Purchase agreement announcement. Yesterday, BioSig Technologies announced a purchase and leasing agreement with Kansas City Heart Institute at Overland Park Regional Medical Center. While terms were not disclosed, Kansas City Heart has multiple EP labs that could benefit from the PURE EP signal processing technology.National master agreement also announced. Concurrent with the Kansas City Heart commercial announcement, BioSig also announced a national purchase agreement. While not named in the release, it is likely the master was signed with HCA Healthcare given that Kansas City Heart Institute is part of the HCA Midwest Heart and Vascular group. One of the largest hospital networks with 175 general and acute hospitals, HCA represents a substantial opportunity moving forward. Read More >>